title: Precision medicine and the FDA's draft guidance on laboratory-developed tests.
authors.affiliation: 1] Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA. [2] The Blackstone Group, London, United Kingdom.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Hwang
authors.affiliation: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Lisa Soleymani
authors.initials: LS
authors.lastname: Lehmann
authors.affiliation: Program on Regulation, Therapeutics and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D033161:Government Regulation; D006801:Humans; D057285:Precision Medicine; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence